Cencora, Inc. COR
306.92
(2.95)
(0.95%)
as of 25 Sep
- Market cap
- $59.1B
- P/E
- 22.7×
Follow COR
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Cencora, Inc. (COR) Book value per share
Cencora, Inc.'s book value per share at the end of fiscal 2025 was 9.0×, up 127.4% from 4.0× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 16.8×. Over the past ten years it has ranged from −4.1× (fiscal 2020) to 14.2× (fiscal 2019); the current reading is higher than 64% of that period. Cencora, Inc. ranks 2nd of 11 Medical Distribution companies by book value per share.
Book value per share, annual
Annual
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 9.0× | 127.43% |
| FY2024 | 4.0× | 20.46% |
| FY2023 | 3.3× | 862.30% |
| FY2022 | 0.3× | (87.95%) |
| FY2021 | 2.8× | — |
| FY2020 | −4.1× | — |
| FY2019 | 14.2× | 1.74% |
| FY2018 | 14.0× | 48.08% |
| FY2017 | 9.5× | (5.79%) |
| FY2016 | 10.0× | 254.55% |
Quarterly
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 16.8× | (8.99%) |
| Mar 2026 | 18.4× | 70.75% |
| Dec 2025 | 10.8× | 19.72% |
| Sep 2025 | 9.0× | (20.94%) |
| 42 more quarters | Free account |
Against its own ten years
Low −4.1×
High 14.2×
Ten-year median
4.0×
Current reading's percentile
64
Book value per share against peers
| Company | Book value per share |
|---|---|
| HSIC Henry Schein, Inc. compare | 33.6× |
| COR Cencora, Inc. | 16.8× |
| COSM Cosmos Health Inc. compare | 0.3× |
| AHG Akso Health Group Sponsored ADR compare | 0.0× |
| FOCL FocalTherics compare | −0.1× |
| ACH Accendra Health, Inc. compare | −7.2× |
| CAH Cardinal Health, Inc. compare | −11.5× |
| YI 111, Inc. Sponsored ADR compare | −12.5× |
| MCK McKesson Corporation compare | −32.6× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on COR
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- The full statement